Literature DB >> 21519018

Myelodysplastic syndromes: dissecting the heterogeneity.

Peter L Greenberg.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21519018     DOI： 10.1200/JCO.2011.35.2211

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  6 in total

Review 1.  Murine xenogeneic models of myelodysplastic syndrome: an essential role for stroma cells.

Authors:  Xiang Li; H Joachim Deeg
Journal:  Exp Hematol       Date:  2013-10-11       Impact factor: 3.084

2.  Tumor suppressor gene BLU is frequently downregulated by promoter hypermethylation in myelodysplastic syndrome.

Authors:  Yujuan Yang; Qingxia Zhang; Feng Xu; Lingyun Wu; Qi He; Xiao Li
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-15       Impact factor: 4.553

Review 3.  Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: the past decade.

Authors:  Ekapun Karoopongse; H Joachim Deeg
Journal:  Expert Rev Clin Immunol       Date:  2012-05       Impact factor: 4.473

4.  Distribution of serum erythropoietin levels in lower risk myelodysplastic syndrome cases with anemia.

Authors:  Kumi Nakazaki; Yasuhito Nannya; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2013-12-05       Impact factor: 2.490

5.  Guideline-based indicators for adult patients with myelodysplastic syndromes.

Authors:  Kristina Stojkov; Tobias Silzle; Georg Stussi; David Schwappach; Juerg Bernhard; David Bowen; Jaroslav Čermák; Avinash G Dinmohamed; Corien Eeltink; Sabrina Eggmann; Pierre Fenaux; Ulrich Germing; Manuel Haschke; Eva Hellstrom-Lindberg; Monika Heger; Arjan A van de Loosdrecht; Jakob Passweg; Michael Pfeilstöcker; Uwe Platzbecker; Luca Malcovati; António Medina de Almeida; Moshe Mittelman; Christine Morgenthaler; David P Steensma; Valeria Santini; Reinhard Stauder; Argiris Symeonidis; Sämi Schär; Charlotte Maddox; Theo de Witte; Julia Bohlius; Nicolas Bonadies
Journal:  Blood Adv       Date:  2020-08-25

6.  Proteomic Analysis Reveals Autophagy as Pro-Survival Pathway Elicited by Long-Term Exposure with 5-Azacitidine in High-Risk Myelodysplasia.

Authors:  Alessandra Romano; Cesarina Giallongo; Piera La Cava; Nunziatina L Parrinello; Antonella Chiechi; Calogero Vetro; Daniele Tibullo; Francesco Di Raimondo; Lance A Liotta; Virginia Espina; Giuseppe A Palumbo
Journal:  Front Pharmacol       Date:  2017-04-26       Impact factor: 5.810
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.